scispace - formally typeset
K

Koji Yoshimoto

Researcher at Kyushu University

Publications -  114
Citations -  2693

Koji Yoshimoto is an academic researcher from Kyushu University. The author has contributed to research in topics: Glioma & Temozolomide. The author has an hindex of 25, co-authored 112 publications receiving 2115 citations. Previous affiliations of Koji Yoshimoto include Kagoshima University.

Papers
More filters
Journal ArticleDOI

Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.

TL;DR: APT imaging can predict the histopathological grades of adult diffuse gliomas using a novel molecular MRI technique to detect endogenous mobile proteins and peptides through chemical exchange saturation transfer.
Journal ArticleDOI

MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance

TL;DR: The results suggest that miR-196 may play a role in the malignant progression of gliomas and may be a prognostic predictor in glioblastomas.
Journal ArticleDOI

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

TL;DR: The findings suggest that a combination of IDH, TERT, and MGMT refines the classification of grade II-IV diffuse gliomas, and patients with TERT mutant-MGMT unmethylated GBM have the poorest prognosis.
Journal ArticleDOI

Differentiation of high-grade and low-grade diffuse gliomas by intravoxel incoherent motion MR imaging

TL;DR: IVIM imaging is useful in differentiating HGGs from LGGs, and the f-values were significantly larger in HGG than in LGG and correlated with relative cerebral blood volume.
Journal ArticleDOI

Differentiating primary CNS lymphoma from glioblastoma multiforme: Assessment using arterial spin labeling, diffusion-weighted imaging, and 18F-fluorodeoxyglucose positron emission tomography

TL;DR: ASL perfusion imaging is useful for differentiating PCNSLs from GBMs as well as DWI and FDG-PET in differentiating primary central nervous system lymphomas from glioblastoma multiformes.